A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SRH / single radial haemolysis

[Related PubMed/MEDLINE]
Total Number of Papers: 125
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SRH  (>> Co-occurring Abbreviation)
Long Form:   single radial haemolysis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Phase 2/3 double blinded, randomized, placebo-controlled study in healthy adult participants in Vietnam to examine the safety and immunogenicity of an inactivated whole virion, alum adjuvanted, A(H5N1) influenza vaccine (IVACFLU-A/H5N1). HI, MN
2020 Equine Influenza Serological Methods. EIV, HI
2020 Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection. HA, HI, PVNT
2019 A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu) in healthy adults. HI, TIVc
2019 Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage. EI, EIV, NP, RESPE
2018 Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses. HI, MN
2018 Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses. ---
2018 Serological investigation of racehorse vaccination against equine influenza in Morocco. EI, ELISA, HI
2018 The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines? HI, MN
10  2018 The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain. EI, EIV, FC2, HI
11  2017 Single radial haemolysis compared to haemagglutinin inhibition and microneutralization as a correlate of protection against influenza A H3N2 in children and adolescents. HAI, MN
12  2016 Controlling equine influenza: Traditional to next generation serological assays. HI, PVNA, VN
13  2015 A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine--Assessing the immunogenicity and safety in an open label, uncontrolled study. GMR, HI
14  2015 Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets. ASC, HI, HPAI, MN
15  2015 Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults. HI, MN
16  2015 The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses. EI
17  2015 Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses. ---
18  2014 A phase II study of an investigational tetravalent influenza vaccine formulation combining MF59: adjuvanted, pre-pandemic, A/H5N1 vaccine and trivalent seasonal influenza vaccine in healthy adults. HI, MN
19  2014 Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals. HI, MN, pp-NT
20  2014 Equine influenza serological methods. EIV, HI
21  2014 Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu): an open label, uncontrolled study. GMTs, HI
22  2014 Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future. EMA, HI, VN
23  2013 A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. c-di-GMP, CSN, HA, HI
24  2013 Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza. EI
25  2013 Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012). EI
26  2013 Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines. CMI, IFN-gamma
27  2013 The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA). DIVA, EI, EIV, HI
28  2012 A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. HI, MN
29  2012 Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects. HI, MN
30  2012 Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming. MN
31  2012 Homologous and heterologous antibody responses to a one-year booster dose of an MF59() adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjects. HI, MN
32  2012 ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse. CMI, EIV, HA, IFN-gamma, NA
33  2012 Safety and immunogenicity of an MF59()-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. GMR, HI, MN
34  2012 Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine. MN
35  2012 T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. HA, HI, MN, Th1
36  2012 The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine. ASCs, HA, HI, SU, Th1
37  2012 The use of equine influenza pseudotypes for serological screening. HA, PV, PVNAs
38  2012 Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study. AE, GMR, GMT, HI, ITT, MN, PP
39  2011 A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study. EIV, HA
40  2011 Collaborative study on influenza vaccine clinical trial serology - part 2: reproducibility study. BSP, CHMP, EU, HI, PR
41  2011 Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial. HA, HI, MN
42  2010 A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus. EI, EIV
43  2010 A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses. CHMP, HI, MN
44  2010 Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. HI, MN
45  2010 Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. HA, HI
46  2010 Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence. HI
47  2010 Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. AE, HA, HI, MN, VLP
48  2010 Surveillance of equine respiratory viruses in Ontario. ---
49  2009 MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. HI, MN
50  2008 Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host. CMI, EIV, ISCOM, PBL
51  2008 The effect of age on serum antibody titers after rabies and influenza vaccination in healthy horses. ---
52  2007 Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/EQ/South Africa/4/03 - horse antiserum biological reference preparation. BSP, EDQM, HI, OIE
53  2007 Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus. IFN, IL, TNF
54  2006 Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. EIV, IFN-gamma, PBMC
55  2006 Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine. EIV
56  2006 [Application of single radial hemolysis technique for diagnosis of influenza A (H5N1)]. ---
57  2004 Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines. ---
58  2003 Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population. GMTs, HI, MN
59  2002 Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines--a retrospective analysis of three independent field trials. AUC
60  2002 The 1999-2000 avian influenza (H7N1) epidemic in Italy: veterinary and human health implications. HPAI, LPAI, MN
61  2002 Time-resolved fluorometric immunoassay for rubella antibody--a useful method for serosurveillance studies. TR-FIA
62  2001 Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. ---
63  2000 Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). ---
64  2000 Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine. ---
65  1999 Equine influenza in the United Kingdom in 1998. ---
66  1996 Single radial haemolysis for the detection of goat pox virus antigen and antibody. AGPT, CIE
67  1995 The effect of changing single radial hemolysis assay method when quantifying influenza A antibodies in serum. ---
68  1995 The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses. HI, VN
69  1994 Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. ---
70  1994 Comparison of influenza serological techniques by international collaborative study. HI
71  1992 Immunization of elderly volunteers with the 1988-89 inactivated whole influenza vaccine: assessment of antibody responses by haemagglutination inhibition and single radial haemolysis tests. HI
72  1988 Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus. ---
73  1988 [The detection of antibodies against influenza A viruses (H1N1, H3N2) in swine with the single radial hemolysis (SRH) and the hemagglutination inhibition (HAH) tests]. HAH
74  1987 Reverse phase passive haemagglutination test for the detection of rinderpest antigen. CIE, RPHA
75  1987 Use of single radial haemolysis for assessing antibody response to influenza virus vaccines in animals. HAI
76  1986 Blocking of IgM-mediated single radial haemolysis by IgA and non-complement-fixing IgM anti-type-III pneumococcal antibodies. CF, NCF
77  1986 Epidemiological study of swine influenza virus as a component of the respiratory disease complex of feeder calves. HI, VN
78  1986 Single radial hemolysis test for the detection of rinderpest antibody. CIE, SN
79  1986 Single-radial-haemolysis test for diagnosing flavivirus infections, particularly Japanese encephalitis. CF, HI
80  1985 A single-radial haemolysis technique for measurement of antibody to influenza virus neuraminidase in equine sera. NA
81  1985 Comparison of the performance and reproducibility of various serological methods and diagnostic kits for the detection of rubella antibodies. CV, HAI, SDG
82  1985 Comparison of various serological methods and diagnostic kits for the detection of acute, recent, and previous rubella infection, vaccination, and congenital infections. HAI, HIT, SDG
83  1985 Direct enzyme immunoassay for detection of specific IgG antibody to rubella virus by use of labelled antigen. EIA, HI, IgG, RIA, TR-FIA
84  1985 Failed rubella immunization in adults: association with immunologic and virological abnormalities. ELISA, HAI
85  1985 Morphology and antigenicity studies on reassortant influenza (H3N2) viruses for use in inactivated vaccines. HI
86  1985 Mosquito-borne arboviruses in Norway: further isolations and detection of antibodies to California encephalitis viruses in human, sheep and wildlife sera. CE, HI, IEOP, IFAT
87  1985 Persistence of rubella antibodies after vaccination: detection after experimental challenge. RIA
88  1984 A comparison of three vaccines against respiratory syncytial virus in calves. MV, RSV
89  1984 Altered hemolysis in single radial hemolysis from a single serum sample as an indicator of recent primary rubella virus infection. SM, SZ
90  1984 Antibody responses to mumps virus proteins in natural mumps infection and after vaccination with live and inactivated mumps virus vaccines. EIA, HI, HN
91  1984 Determination of rubella immunity by latex agglutination: its place in clinical routines. HI, RSC
92  1984 Diagnosis of postnatally acquired rubella by use of three enzyme-linked immunosorbent assays for specific immunoglobulins G and M and single radial hemolysis for specific immunoglobulin G. ELISAs, IgG
93  1984 Experimental pneumonia in gnotobiotic calves produced by respiratory syncytial virus. RSV
94  1984 Inactivated influenza virus vaccines in man: a comparative study of subunit and split vaccines using two methods for assessment of antibody responses. CTAB, HI
95  1984 Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. HI
96  1984 Reactions of extracts of Reiter treponeme with syphilitic and non-syphilitic human sera in the single radial haemolysis technique. CWR, FTA-ABS, RPCFT, VDRL
97  1984 Results of a two-year study of humoral immunity to influenza A and B viruses in children under the age of 14 years in Moscow and its suburbs. ---
98  1984 Vaccination with a live RA 27/3 strain rubella vaccine (Rudivax), a follow-up study. HAI
99  1984 [Demonstration of Rubella-specific IgG and IgM antibody (sub) classes using the enzyme immunoassay (EIA)]. EIA, HI, sub
100  1983 Antibody assay for measles virus: comparisons of immune-adherence haemagglutination, single radial haemolysis, enzyme immunoassay and haemagglutination inhibition. HAI, IAHA